World Orphan Drug Congress convenes the global rare disease ecosystem to accelerate innovation and drive meaningful change. We are offering a limited number of complimentary passes to investors focused on rare diseases and orphan drugs, providing access to patient-informed insights, emerging science, and strategic discussions shaping the future of rare disease development and investment.